Anavex Life Sciences Corp (AVXL)

[Gator328]

I don’t think we’ll see anything close to 50% market penetration. 10-20% is more realistic until the generic version becomes more available.

Insurance companies are always reluctant to approve new drugs until there are years of real world data(not clinical trials). And in most of the developed world there’s a single payer system that has significant bargaining power to negotiate lower drug prices.

$300-$500 is probably a more realistic best case scenario and even that’s a stretch. $125 and I’ll bet we see Dr. Missling accept a buyout offer.